DEAKIN researchers are exploring the potential use of medicinal cannabis for pain management in people with endometriosis.
The 'EndoCannED' trial will examine if prescribing medicinal cannabis instead of opioids can reduce emergency department (ED) presentations among people living with the condition.
Prof Antonina Mikocka-Walus from Deakin's Centre for Social and Early Emotional Development said insufficient pain control can lead to people presenting to ED with breakthrough pain, putting pressure on an already busy health system.
"Opioids are often ineffective in managing pain from endometriosis and are not suitable for the long-term treatment required by those with the condition," explained Mikocka-Walus.
"Women with endometriosis have a four times greater risk of chronic opioid use compared to women without it.
"Despite substantial use of these medications, most people with endometriosis in Australia report poor pain and symptom control."
The three-month project will involve 63 patients, living in Victoria, who will be monitored by researchers to learn whether the use of medicinal cannabis reduces the need for them to present to emergency departments.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 May 23
